Elena Barbuti
| Titolo | Pubblicato in | Anno |
|---|---|---|
| Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study | NEUROTHERAPEUTICS | 2025 |
| Brain reserve and timing of clinical onset in multiple sclerosis | MULTIPLE SCLEROSIS | 2024 |
| Should we treat pediatric radiologically isolated syndrome? An 18-year follow-up case report | FRONTIERS IN NEUROLOGY | 2023 |
| Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study | NEUROLOGY AND THERAPY | 2022 |
| Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases | FRONTIERS IN NEUROLOGY | 2021 |
| Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial | THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS | 2021 |
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma